Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Non-Hodgkin 5Multiple Myeloma 4Melanoma 3Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Solid Tumors 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immune-related Adverse Events 1Hematologic Neoplasms 1Glioblastoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bone Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 2Proton Therapy 2tocilizumab 1cobimetinib 1Vemurafenib 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Methionine 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Craniopharyngioma × tocilizumab × Clear all
NCT03970226 2026-02-17

Tocilizumab in Children With ACP

University of Colorado, Denver

Phase EARLY_PHASE1 Active not recruiting
9 enrolled
CNS

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡